Kotak 
Dealstreet

Kotak PE invests 400 crore in Biorad Medisys: Luthra advises

Kotak Strategic Situations India Fund II invested ₹400 crore.

Bar & Bench

Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has made an investment of up to ₹400 Crore in medical device manufacturer Biorad Medisys Private Limited.

Luthra and Luthra Law Offices India represented Kotak in this investment deal.

The transaction team consisted of Nishant Singh (Partner), Prachi Pandit (Managing Associate), Saksham Madan (Managing Associate), Manushi Shah (Associate), Varshini Ramesh (Associate), Aditi Nagpal (Associate), Charith Reddy (Associate), Kashish Singhal (Associate), Maitri Meghani (Associate) and Aashi Shah (Associate).

Nishant Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Follow Bar and Bench channel on WhatsApp

Download the Bar and Bench Mobile app for instant access to the latest legal news.

Also Read

New adjournment norms at Supreme Court: Reasons, past adjournments must be disclosed; opposing side can object

Urgent need for changes to CPC, IT Rules for dynamic injunctions to be effective: Delhi High Court to Centre

Madras High Court restrains illegal broadcast, streaming of Dhurandhar 2

Khaitan & Co advises Magnum Ice Cream Company on stake acquisition in Kwality Wall's

Arbitration rising: India’s path to Asia’s top seat

SCROLL FOR NEXT